The impact of first and further decompensation in patients with metabolic-dysfunction associated compensated advanced chronic liver disease

被引：0

作者：

Pennisi, G. ^{[1
]}

Di Maria, G. ^{[2
]}

Wong, V. Wai-Sun ^{[3
]}

de Ledinghen, V. ^{[4
]}

Sebastiani, G. ^{[5
]}

Vigano, M. ^{[6
]}

Fracanzani, A. L. ^{[7
]}

Miele, L. ^{[8
]}

Bugianesi, E. ^{[9
]}

Ekstedt, M. ^{[10
]}

D'Ambrosio, R. ^{[11
]}

Schepis, F. ^{[12
,13
]}

Marra, F. ^{[14
,15
]}

Aghemo, A. M. ^{[16
]}

Svegliati-Baroni, G. ^{[17
]}

Persico, M. ^{[18
]}

Valenti, L. ^{[7
,19
]}

Berzigotti, A. ^{[20
]}

George, J. ^{[21
]}

Ravaioli, F. ^{[22
]}

Armandi, A. ^{[9
]}

Calvaruso, V. ^{[1
]}

Enea, M. ^{[2
]}

Lin, H. ^{[3
]}

Infantino, G. ^{[1
]}

Masarone, M. ^{[18
]}

Pugliese, N. ^{[16
]}

Tulone, A. ^{[1
]}

Di Marco, V. ^{[1
]}

Camma, C. ^{[1
]}

Petta, S. ^{[1
]}

机构：

[1] Univ Palermo, Sect Gastroenterol & Hepatol, Dipartimento Promoz Salute Materno Infantile Med, Palermo, Italy

[2] Univ Palermo, Dipartimento Promoz Salute Materno Infantile Med, Palermo, Italy

[3] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China

[4] Bordeaux Univ Hosp, Hop Haut Leveque, INSERM U1053, Ctr Invest Fibrose Hepat, Pessac, France

[5] McGill Univ, Div Gastroenterol & Hepatol, Ctr Hlth, Montreal, PQ, Canada

[6] Univ Milan, Osped San Giuseppe, Hepatol Unit, Milan, Italy

[7] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[8] Fdn Policlin Gemelli IRCCS, DiSMeC Dept Sci Med & Chirurg, I-00168 Rome, Italy

[9] Univ Torino, Dept Med Sci, Div Gastroenterol, Turin, Italy

[10] Linkoping Univ, Dept Hlth Med & Caring Sci, Div Diagnost & Specialist Med, Linkoping, Sweden

[11] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy

[12] Azienda Osped Univ Modena, Div Gastroenterol, Modena, Italy

[13] Univ Modena & Reggio Emilia, Modena, Italy

[14] Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy

[15] Res Ctr DENOTHE, Florence, Italy

[16] IRCCS Humanitas Res Hosp, Dept Gastroenterol, Div Internal Med & Hepatol, I-20089 Rozzano, Italy

[17] Univ Politecn Marche, Liver Injury & Transplant Unit, I-60121 Ancona, Italy

[18] Univ Salerno, Internal Med & Hepatol Unit, Scuola Med Salernitana, Dept Med & Surg, Salerno, Italy

[19] Fdn IRCCS Ca Granda Osped Maggiore Policlin IRCCS, Dept Transfus Med, Translat Med, Milan, Italy

[20] Univ Bern, Bern Univ Hosp, Inselspital, Dept Visceral Surg & Med, Bern, Switzerland

[21] Univ Sydney, Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW, Australia

[22] IRCCS Azienda Osped Univ Bologna, Div Internal Med Hepatobiliary & Immunoallerg Dis, Bologna, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷

关键词：

D O I：

10.1016/j.dld.2024.08.005

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OC-01

引用

页码：S316 / S317

页数：2

共 50 条

[41] IMMUNE DYSREGULATION IN METABOLIC-DYSFUNCTION FATTY LIVER DISEASE: A CLINICIAN AND LABORATORY PERSPECTIVE
Stoica, Victor Constantin
Manea, Marina
Caragea, Andreea
Iacob, Mirela
Constantinescu, Ileana
HLA, 2021, 97 (04) : 321 - 321
[42] Risk stratification of decompensation using liver stiffness and platelet counts in compensated advanced chronic liver disease (CHESS2102)
Liu, Yanna
Liu, Chuan
Li, Jia
Kim, Tae Hyung
Enomoto, Hirayuki
Qi, Xiaolong
JOURNAL OF HEPATOLOGY, 2022, 76 (01) : 248 - 250
[43] Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
Michalczuk, Matheus Truccolo
Longo, Larisse
Keingeski, Melina Belen
Basso, Bruno de Souza
Guerreiro, Gabriel Tayguara Silveira
Ferrari, Jessica T.
Vargas, Jose Eduardo
Oliveira, Claudia P.
Uribe-Cruz, Carolina
Cerski, Carlos Thadeu Schmidt
Filippi-Chiela, Eduardo
Alvares-da-Silva, Mario Reis
WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (01) : 75 - 90
[44] IMMUNOGLOBULIN SUBTYPES AND COMPLEMENT LEVELS EXHIBIT DISTINCT DYNAMICS ACROSS ADVANCED CHRONIC LIVER DISEASE STAGES AND PREDICT FIRST OR FURTHER DECOMPENSATION
Simbrunner, Benedikt
Hartl, Lukas
Jachs, Mathias
Bauer, David
Scheiner, Bernhard
Paternostro, Rafael
Staettermayer, Albert
Pinter, Matthias
Trauner, Michael H.
Mandorfer, Mattias
Reiberger, Thomas
HEPATOLOGY, 2021, 74 : 1221A - 1222A
[45] A PROSPECTIVE ASSESSMENT OF THE IMPACT OF DECOMPENSATION OF CIRRHOSIS ON PATIENT-REPORTED OUTCOMES IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
O'Connor, Ian
Mospan, Andrea
Schoen, Cheryl
Barritt, Alfred
Sanyal, Arun
HEPATOLOGY, 2024, 80 : S843 - S844
[46] Risk Factors for Advanced Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
Sachar, Moniyka
Pan, Jason
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S561 - S561
[47] Apolipoprotein C-III in association with metabolic-dysfunction associated steatotic liver disease: A large, multicenter study
Kouvari, Matina
Valenzuela-Vallejo, Laura
Guatibonza-Garcia, Valentina
Verrastro, Ornella
Axarloglou, Evangelos
Mylonakis, Sophia C.
George, Jacob
Papatheodoridis, Georgios
Mingrone, Geltrude
Mantzoros, Christos S.
CLINICAL NUTRITION, 2024, 43 (12) : 101 - 108
[48] Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier
Choudhury, Ashok
Rajaram, Ruveena
Sarin, Shiv Kumar
HEPATOLOGY INTERNATIONAL, 2024, 18 (SUPPL 2) : 941 - 958
[49] Advanced Liver Fibrosis Impairs Cardiorespiratory Fitness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Sogbe, Miguel
Hummer, Breianna
Stine, Jonathan G.
Lizaola-Mayo, Blanca
Forman, Daniel E.
Vargas, Hugo E.
Duarte-Rojo, Andres
DIGESTIVE DISEASES AND SCIENCES, 2025, : 1530 - 1539
[50] Opioid Prescribing to Patients with Chronic Liver Disease Is Associated with New Hepatic Decompensation
Rogal, Shari S.
Gmelin, Theresa
Liebschutz, Jane
Fine, Michael J.
Jonassaint, Naudia L.
Good, Chester B.
Gellad, Walid
HEPATOLOGY, 2018, 68 : 1143A - 1144A

← 1 2 3 4 5 →